CHD Chemicals Ltd Upgraded to Sell Amid Mixed Technical and Financial Signals

Quality Assessment: Weak Fundamentals Persist

CHD Chemicals continues to struggle with its core financial health, reflected in a weak long-term fundamental strength rating. The company reported flat financial results for the third quarter of fiscal year 2025-26, with operating losses and a negative EBITDA of ₹-0.23 crore. This negative EBITDA underscores ongoing operational inefficiencies and cash flow challenges.

Profitability remains subdued, with an average Return on Equity (ROE) of just 1.04%, indicating minimal returns generated on shareholders’ funds. The company’s ability to service debt is also a concern, as evidenced by a high Debt to EBITDA ratio of 6.72 times, signalling elevated financial risk and limited flexibility to manage liabilities.

These factors collectively maintain CHD Chemicals’ low-quality grade, reinforcing the rationale behind the cautious stance despite recent technical improvements.

Valuation: Risky and Historically Low

From a valuation perspective, CHD Chemicals remains a risky proposition. The stock is trading at levels that are considered expensive relative to its historical averages, despite its micro-cap status. Over the past year, the stock has generated a negative return of -3.15%, underperforming the broader BSE500 index consistently over the last three years.

Its 52-week price range between ₹4.11 and ₹7.24, with the current price at ₹6.15, suggests limited upside potential given the company’s financial struggles. The stock’s inability to keep pace with benchmark indices such as the Sensex, which has delivered a 10-year return of 188.28%, further highlights valuation concerns.

Financial Trend: Flat Performance Amidst Operational Challenges

CHD Chemicals’ financial trend remains largely flat, with no significant improvement in profitability or revenue growth. The company’s operating losses and negative EBITDA in the recent quarter reflect ongoing challenges in scaling operations or improving margins. While profits have risen marginally by 6% over the past year, this has not translated into meaningful returns for investors.

The stock’s returns over various periods illustrate mixed performance: a strong 21.06% gain over the past month contrasts with a 3.15% loss over the last year and a steep 53.37% decline over five years. This inconsistency underscores the company’s volatile financial trajectory and the need for cautious investor appraisal.

Technical Analysis: Shift to Mildly Bullish Momentum

The primary driver behind the upgrade from Strong Sell to Sell is the improvement in CHD Chemicals’ technical indicators. The technical trend has shifted from sideways to mildly bullish, signalling a potential positive momentum in the near term.

Key technical signals include a bullish MACD on the weekly chart and mildly bullish readings on the monthly chart. Bollinger Bands also indicate bullish trends on both weekly and monthly timeframes, suggesting increased price volatility with upward bias. The KST indicator is bullish on the weekly scale but bearish monthly, reflecting some mixed signals but an overall positive short-term outlook.

However, some caution remains as daily moving averages are mildly bearish, and the Dow Theory shows no clear trend weekly but mildly bullish monthly. The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no strong signal, indicating the stock is not yet overbought or oversold.

These technical improvements have contributed to a 6.03% day change in the stock price, with the current price at ₹6.15, up from the previous close of ₹5.80. The stock’s intraday high reached ₹6.79, reflecting increased buying interest.

Comparative Performance: Underperformance Against Benchmarks

Despite recent technical gains, CHD Chemicals has underperformed key market benchmarks over the medium to long term. The stock’s year-to-date return of 13.26% outpaces the Sensex’s negative 10.81% return, but over one, three, five, and ten-year periods, the stock has lagged significantly behind the benchmark indices.

This persistent underperformance, coupled with weak fundamentals, suggests that while technical factors may offer short-term trading opportunities, the stock remains a risky proposition for long-term investors.

Majority shareholding remains with non-institutional investors, which may limit the stock’s liquidity and institutional interest, further contributing to its micro-cap classification and associated risks.

Outlook and Investor Considerations

While the upgrade to a Sell rating from Strong Sell reflects a modest improvement in technical momentum, CHD Chemicals remains burdened by weak financial fundamentals and valuation risks. Investors should weigh the mildly bullish technical signals against the company’s flat financial performance, negative EBITDA, and high leverage.

The stock’s micro-cap status and majority non-institutional ownership add layers of risk, including lower liquidity and potential volatility. Given the company’s consistent underperformance relative to benchmarks over multiple years, cautious investors may prefer to explore alternative opportunities with stronger fundamentals and more favourable valuations.

In summary, CHD Chemicals’ recent technical rebound offers a short-term positive signal, but the broader investment thesis remains challenged by operational losses and financial constraints. The Sell rating reflects this balanced view, advising prudence while recognising the potential for limited upside driven by technical factors.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →